(Q45765792)

15 December 2017

title

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. (English)

1 reference

15 December 2017

0 references

Falsey AR

1

1 reference

15 December 2017

Walsh EE

series ordinal

2

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

14

1 reference

15 December 2017

page(s)

1214-1218

1 reference

15 December 2017

issue

13

1 reference

15 December 2017

Acute Lower Respiratory Illness in Elderly Patients with Respiratory Syncytial Virus Infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Outbreak of respiratory syncytial virus infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

An outbreak of respiratory syncytial virus infection in an old people's home

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Respiratory syncytial virus infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Acute respiratory tract infection in daycare centers for older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Respiratory syncytial virus or influenza?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Immunodeficiency of the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Immunological Principles and Emerging Strategies of Vaccination for the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Humoral immunity to respiratory syncytial virus infection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Antibody induction by influenza vaccines in the elderly: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

Relation of chronic disease and immune response to influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900030-8

7 January 2021

10.1016/S0264-410X(96)00030-8

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

8961507

1 reference

15 December 2017